OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Burgess, Hearing on Examining FDA's Generic Drug and Biosimilar User Fee Programs

Hearing

Date: March 2, 2017
Location: Washington, DC
Issues: Health and Health Care

Only available in PDF format; please see source to view document.


Source
arrow_upward